NOVELLI, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 243
Totale 243
Nazione #
IT - Italia 243
Totale 243
Città #
Genova 138
Rapallo 77
Genoa 24
Bordighera 4
Totale 243
Nome #
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles, file e268c4cc-6ece-a6b7-e053-3a05fe0adea1 85
New arylsparteine derivatives as positive inotropic drugs, file e268c4ca-6a39-a6b7-e053-3a05fe0adea1 78
null, file e268c4ca-ed2f-a6b7-e053-3a05fe0adea1 17
Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and beta-Amyloid (Abeta) Aggregation, file e268c4ce-a635-a6b7-e053-3a05fe0adea1 17
(+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype, file e268c4c6-19f2-a6b7-e053-3a05fe0adea1 9
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines, file e268c4c6-1874-a6b7-e053-3a05fe0adea1 7
On the self-condensation of aminoguanidine leading to 1,1,4,10,10-pentaamino-2,3,5,6,8,9-hexaazadeca-1,3,5,7,9-pentaene (Structure elucidation through X-ray powder diffraction), file e268c4c6-19f3-a6b7-e053-3a05fe0adea1 6
Novel celecoxib analogues inhibit glial production of prostaglandinE2, nitric oxide, and oxygen radicals reverting the neuroinflammatoryresponses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide, file e268c4c9-d5a2-a6b7-e053-3a05fe0adea1 5
Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and beta-Amyloid (Abeta) Aggregation, file e268c4c6-9592-a6b7-e053-3a05fe0adea1 4
Prevalence of Long COVID Symptoms Related to SARS-CoV-2 Strains, file a732c44e-f8ca-4e84-b6f1-efc1c1fddb48 3
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells, file e268c4c9-b3b5-a6b7-e053-3a05fe0adea1 3
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5, file e268c4c6-9428-a6b7-e053-3a05fe0adea1 2
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles, file e268c4ca-6a42-a6b7-e053-3a05fe0adea1 2
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents, file e268c4ca-76cc-a6b7-e053-3a05fe0adea1 2
Antiviral activity of benzimidazole derivatives. II Antiviral activity of 2-phenylbenzimidazole derivatives., file e268c4c5-f413-a6b7-e053-3a05fe0adea1 1
Acridine derivatives as anti-BVDV agents, file e268c4c6-12e4-a6b7-e053-3a05fe0adea1 1
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation, file e268c4c6-1348-a6b7-e053-3a05fe0adea1 1
Totale 243
Categoria #
all - tutte 711
article - articoli 709
book - libri 0
conference - conferenze 2
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.422


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20196 0 0 0 0 0 0 0 0 0 0 0 6
2019/202016 2 0 1 3 0 0 2 0 0 0 0 8
2020/202163 0 8 1 7 0 6 18 7 4 4 4 4
2021/202256 12 0 1 4 2 3 0 4 2 5 19 4
2022/202382 3 8 12 8 10 16 2 7 4 8 4 0
2023/202419 4 0 3 0 2 0 3 5 2 0 0 0
Totale 243